Findings in this study show that the difference between T1D patients and their age-matched controls in terms of serum TGF-β concentration is mostly related to the disease status because patients and controls have been matched for notable criteria such as age. This evidence concerns the gene TGFB1 and type 1 diabetes mellitus.